BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25844357)

  • 1. De novo malignancy after liver transplantation: a single-center experience of 14 cases.
    Gao PJ; Gao J; Li Z; Hu ZP; Zhu JY
    Ann Surg Treat Res; 2015 Apr; 88(4):222-8. PubMed ID: 25844357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of De Novo Malignancy After Liver Transplant: A Single-Center Study.
    Kim S; Rovgaliyev B; Lee JM; Lee KW; Hong SK; Cho JH; Yoon KC; Yi NJ; Suh KS
    Transplant Proc; 2021; 53(1):200-206. PubMed ID: 32409224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo Malignancy After Living Donor Liver Transplantation: A Large Volume Experience.
    Tiwari A; Saigal S; Choudhary NS; Saha S; Rastogi A; Bhangui P; Saraf N; Srinivasan T; Yadav SK; Gautam D; Nundy S; Soin AS
    J Clin Exp Hepatol; 2020; 10(5):448-452. PubMed ID: 33029053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant malignancy in liver transplantation: a single center experience.
    Hsiao CY; Lee PH; Ho CM; Wu YM; Ho MC; Hu RH
    Medicine (Baltimore); 2014 Dec; 93(28):e310. PubMed ID: 25526480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo head and neck cancer arising in solid organ transplantation recipients: The Asan Medical Center experience.
    Park MJ; Roh JL; Choi SH; Nam SY; Kim SY; Lee YS
    Auris Nasus Larynx; 2018 Aug; 45(4):838-845. PubMed ID: 29150348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo cancers following liver transplantation: a single center experience in China.
    Yu S; Gao F; Yu J; Yan S; Wu J; Zhang M; Wang W; Zheng S
    PLoS One; 2014; 9(1):e85651. PubMed ID: 24475047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Novo Malignancies After Liver Transplantation With 14 Cases at a Single Center.
    Liu ZN; Wang WT; Yan LN;
    Transplant Proc; 2015 Oct; 47(8):2483-7. PubMed ID: 26518956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Novo Malignancies After Liver Transplantation: A Single Institution Experience.
    Egeli T; Unek T; Ozbilgin M; Agalar C; Derici S; Akarsu M; Unek IT; Aysin M; Bacakoglu A; Astarcıoglu I
    Exp Clin Transplant; 2019 Feb; 17(1):74-78. PubMed ID: 29237362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry.
    Park HW; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Namgoong JM; Yoon SY; Park CS; Park YH; Lee HJ; Lee SG
    Transplant Proc; 2012 Apr; 44(3):802-5. PubMed ID: 22483500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
    Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Novo Malignancy After Adult-to-Adult Living Donor Liver Transplantation: A Single-Center Long-Term Experience.
    Masuda Y; Mita A; Ohno Y; Kubota K; Notake T; Shimizu A; Soejima Y
    Transplant Proc; 2023 May; 55(4):952-955. PubMed ID: 37088616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo malignancy post-liver transplantation: a single center, population controlled study.
    Chatrath H; Berman K; Vuppalanchi R; Slaven J; Kwo P; Tector AJ; Chalasani N; Ghabril M
    Clin Transplant; 2013; 27(4):582-90. PubMed ID: 23808800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients.
    Altieri M; Sérée O; Lobbedez T; Segol P; Abergel A; Blaizot X; Boillot O; Boudjema K; Coilly A; Conti F; Chazouillères O; Debette-Gratien M; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Kamar N; Latournerie M; Lebray P; Leroy V; Neau-Cransac M; Pageaux GP; Radenne S; Salamé E; Saliba F; Samuel D; Vanlemmens C; Besch C; Launoy G; Dumortier J
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101514. PubMed ID: 33714907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De Novo Malignancies After Liver Transplantation: Experience of a High-Volume Center.
    Saglam K; Sahin TT; Ogut Z; Ince V; Usta S; Yilmaz S
    J Gastrointest Cancer; 2022 Dec; 53(4):1020-1027. PubMed ID: 34778909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo malignancy in heart transplant recipients: A single center experience in Japan.
    Kimura Y; Yanase M; Mochizuki H; Iwasaki K; Toda K; Matsuda S; Takenaka H; Kumai Y; Kuroda K; Nakajima S; Watanabe T; Ikura MM; Wada K; Matsumoto Y; Seguchi O; Fukushima S; Fujita T; Kobayashi J; Fukushima N
    J Cardiol; 2019 Mar; 73(3):255-261. PubMed ID: 30587457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
    Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
    J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender, Race and Disease Etiology Predict De Novo Malignancy Risk After Liver Transplantation: Insights for Future Individualized Cancer Screening Guidance.
    Bhat M; Mara K; Dierkhising R; Watt KD
    Transplantation; 2019 Jan; 103(1):91-100. PubMed ID: 29377876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy.
    Nasser-Ghodsi N; Mara K; Allen AM; Watt KD
    Clin Transplant; 2022 Aug; 36(8):e14714. PubMed ID: 35594161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and risk factors of de novo skin cancer in the liver transplant recipients.
    Modaresi Esfeh J; Hanouneh IA; Dalal D; Tabba A; Lopez R; Pagadala M; Eghtesad B; Zein NN
    Int J Organ Transplant Med; 2012; 3(4):157-63. PubMed ID: 25013641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.